Skip to main content

Chronic Rhinosinusitis (Diagnosis)

3
Pipeline Programs
4
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Oticara
OticaraTX - Austin
2 programs
1
1
Betamethasone Dipropionate Nasal Cream 0.0644%Phase 21 trial
Betamethasone Dipropionate Nasal Cream 0.0644%Phase 1/21 trial
Active Trials
NCT05220293Terminated2Est. Dec 2023
NCT05882903Recruiting24Est. Jun 2025
Keymed Biosciences
Keymed BiosciencesChina - Chengdu
1 program
1
CM310Phase 21 trial
Active Trials
NCT04805398Completed56Est. Mar 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
OticaraBetamethasone Dipropionate Nasal Cream 0.0644%
Keymed BiosciencesCM310
OticaraBetamethasone Dipropionate Nasal Cream 0.0644%

Clinical Trials (3)

Total enrollment: 82 patients across 3 trials

NCT05882903OticaraBetamethasone Dipropionate Nasal Cream 0.0644%

The Effect of Intra-sinus Application of Betamethasone Dipropionate Nasal Cream on Patients with Chronic Rhinosinusitis Post Functional Endoscopic Sinus Surgery (FESS)

Start: Aug 2023Est. completion: Jun 202524 patients
Phase 2Recruiting
NCT04805398Keymed BiosciencesCM310

Subcutaneously CM310/Placebo in Patients With Chronic Rhinosinusitis With Nasal Polyposis (CROWNS-1)

Start: Apr 2021Est. completion: Mar 202256 patients
Phase 2Completed
NCT05220293OticaraBetamethasone Dipropionate Nasal Cream 0.0644%

Treatment of Eosinophilic Chronic Rhinosinusitis Utilizing Betamethasone Dipropionate Nasal Cream

Start: Feb 2022Est. completion: Dec 20232 patients
Phase 1/2Terminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 82 patients
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.